Cargando…

Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat

BACKGROUND: Notwithstanding increasing knowledge of titanium dioxide nanoparticles (TiO(2) NPs) passing through biological barriers, their biodistribution to the central nervous system (CNS) and potential effects on blood-brain barrier (BBB) physiology remain poorly characterized. METHODS: Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Disdier, Clémence, Devoy, Jérôme, Cosnefroy, Anne, Chalansonnet, Monique, Herlin-Boime, Nathalie, Brun, Emilie, Lund, Amie, Mabondzo, Aloïse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559366/
https://www.ncbi.nlm.nih.gov/pubmed/26337446
http://dx.doi.org/10.1186/s12989-015-0102-8
_version_ 1782388762586644480
author Disdier, Clémence
Devoy, Jérôme
Cosnefroy, Anne
Chalansonnet, Monique
Herlin-Boime, Nathalie
Brun, Emilie
Lund, Amie
Mabondzo, Aloïse
author_facet Disdier, Clémence
Devoy, Jérôme
Cosnefroy, Anne
Chalansonnet, Monique
Herlin-Boime, Nathalie
Brun, Emilie
Lund, Amie
Mabondzo, Aloïse
author_sort Disdier, Clémence
collection PubMed
description BACKGROUND: Notwithstanding increasing knowledge of titanium dioxide nanoparticles (TiO(2) NPs) passing through biological barriers, their biodistribution to the central nervous system (CNS) and potential effects on blood-brain barrier (BBB) physiology remain poorly characterized. METHODS: Here, we report time-related responses from single-dose intravenous (IV) administration of 1 mg/kg TiO(2) NPs to rats, with particular emphasis on titanium (Ti) quantification in the brain. Ti content in tissues was analyzed using inductively coupled plasma mass spectrometry. Integrity and functionality of the BBB as well as brain inflammation were characterized using a panel of methods including RT-PCR, immuno-histo chemistry and transporter activity evaluation. RESULTS: Biokinetic analysis revealed Ti biopersistence in liver, lungs and spleen up to one year after TiO(2) NPs administration. A significant increase of Ti in the brain was observed at early end points followed by a subsequent decrease. In-depth analysis of Ti in the total brain demonstrated quantitative Ti uptake and clearance by brain microvasculature endothelial cells (BECs) with minimal translocation in the brain parenchyma. The presence of Ti in the BECs did not affect BBB integrity, despite rapid reversible modulation of breast cancer resistance protein activity. Ti biopersistence in organs such as liver was associated with significant increases of tight junction proteins (claudin-5 and occludin), interleukin 1β (IL-1β), chemokine ligand 1 (CXCL1) and γ inducible protein-10 (IP-10/CXCL10) in BECs and also increased levels of IL-1β in brain parenchyma despite lack of evidence of Ti in the brain. These findings mentioned suggest potential effect of Ti present at a distance from the brain possibly via mediators transported by blood. Exposure of an in vitro BBB model to sera from TiO(2) NPs-treated animals confirmed the tightness of the BBB and inflammatory responses. CONCLUSION: Overall, these findings suggest the clearance of TiO(2) NPs at the BBB with persistent brain inflammation and underscore the role of Ti biopersistence in organs that can exert indirect effects on the CNS dependent on circulating factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-015-0102-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4559366
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45593662015-09-04 Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat Disdier, Clémence Devoy, Jérôme Cosnefroy, Anne Chalansonnet, Monique Herlin-Boime, Nathalie Brun, Emilie Lund, Amie Mabondzo, Aloïse Part Fibre Toxicol Research BACKGROUND: Notwithstanding increasing knowledge of titanium dioxide nanoparticles (TiO(2) NPs) passing through biological barriers, their biodistribution to the central nervous system (CNS) and potential effects on blood-brain barrier (BBB) physiology remain poorly characterized. METHODS: Here, we report time-related responses from single-dose intravenous (IV) administration of 1 mg/kg TiO(2) NPs to rats, with particular emphasis on titanium (Ti) quantification in the brain. Ti content in tissues was analyzed using inductively coupled plasma mass spectrometry. Integrity and functionality of the BBB as well as brain inflammation were characterized using a panel of methods including RT-PCR, immuno-histo chemistry and transporter activity evaluation. RESULTS: Biokinetic analysis revealed Ti biopersistence in liver, lungs and spleen up to one year after TiO(2) NPs administration. A significant increase of Ti in the brain was observed at early end points followed by a subsequent decrease. In-depth analysis of Ti in the total brain demonstrated quantitative Ti uptake and clearance by brain microvasculature endothelial cells (BECs) with minimal translocation in the brain parenchyma. The presence of Ti in the BECs did not affect BBB integrity, despite rapid reversible modulation of breast cancer resistance protein activity. Ti biopersistence in organs such as liver was associated with significant increases of tight junction proteins (claudin-5 and occludin), interleukin 1β (IL-1β), chemokine ligand 1 (CXCL1) and γ inducible protein-10 (IP-10/CXCL10) in BECs and also increased levels of IL-1β in brain parenchyma despite lack of evidence of Ti in the brain. These findings mentioned suggest potential effect of Ti present at a distance from the brain possibly via mediators transported by blood. Exposure of an in vitro BBB model to sera from TiO(2) NPs-treated animals confirmed the tightness of the BBB and inflammatory responses. CONCLUSION: Overall, these findings suggest the clearance of TiO(2) NPs at the BBB with persistent brain inflammation and underscore the role of Ti biopersistence in organs that can exert indirect effects on the CNS dependent on circulating factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-015-0102-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-04 /pmc/articles/PMC4559366/ /pubmed/26337446 http://dx.doi.org/10.1186/s12989-015-0102-8 Text en © Disdier et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Disdier, Clémence
Devoy, Jérôme
Cosnefroy, Anne
Chalansonnet, Monique
Herlin-Boime, Nathalie
Brun, Emilie
Lund, Amie
Mabondzo, Aloïse
Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title_full Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title_fullStr Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title_full_unstemmed Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title_short Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
title_sort tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559366/
https://www.ncbi.nlm.nih.gov/pubmed/26337446
http://dx.doi.org/10.1186/s12989-015-0102-8
work_keys_str_mv AT disdierclemence tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT devoyjerome tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT cosnefroyanne tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT chalansonnetmonique tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT herlinboimenathalie tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT brunemilie tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT lundamie tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat
AT mabondzoaloise tissuebiodistributionofintravenouslyadministratedtitaniumdioxidenanoparticlesrevealedbloodbrainbarrierclearanceandbraininflammationinrat